Refine by
Wound Treatment Articles & Analysis
151 news found
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, under Florida’s SB 1768, ...
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering treatments for no-option patients in Florida suffering from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease, Angina, Ischemic Cardiomyopathy, non Ischemic Dilated Cardiomyopathy, and Congestive Heart Failure, is pleased to announce additions to ...
Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM, OTCQB: HMTXF; FSE:2VF0), the leading autologous (patient’s own) stem cell therapy company treating no-option patients in Florida suffering in pain from Chronic Limb Threatening Ischemia, Peripheral Arterial Disease and Angina, is pleased to announce its webinar topic for Thursday, August 21, 2025. Croom ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
As an active player in chemical manufacturing and research, Alfa Chemistry exhibits its deep marine chemistry expertise through the addition of marine extracts, oils, and natural products to its portfolio. The company's strategic initiative demonstrates its resolution to utilize marine resources for multiple industries including pharmaceuticals and cosmetics. Marine Natural Products The ...
Methicillin-resistant Staphylococcus aureus (MRSA) is described by the National Institute for Occupational Safety and Health (NIOSH) as a potentially dangerous type of staph bacteria. Staph, which is commonly carried on the skin or in the nose of healthy people, can sometimes cause infections, but most of these skin infections are minor. With MRSA, which is staph that is resistant to an ...
Animal Hydrocolloids Animal-derived hydrocolloids are known for their strong protective colloid properties, good biocompatibility, stable batch, good mechanical strength, and that’s why they are extensively used as substrates or additives in many fields, including food, photography, cosmetics, artificial skin, wound dressings, ophthalmology, wastewater ...
Their versatility extends to applications in cancer treatment and wound healing, making them a significant focus of biotechnological research. ...
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in ...
Creative Enzymes, a renowned biotechnology company, has unveiled a groundbreaking product that is set to revolutionize the health and wellness industry. Yeast-Fermented Vegan Collagen is the latest innovation from Creative Enzymes, offering a sustainable and ethical alternative to traditional animal-derived collagen supplements. As a leading authority in enzyme research and biotechnological ...
In the field of regenerative medicine and tissue engineering, the demand for collagen-based biomaterials is rapidly increasing. Collagen, the most abundant protein in the human body, plays a crucial role in maintaining the structure and function of various tissues. Recognizing the growing need for high-quality collagen products, Alfa Chemistry has emerged as a reliable supplier of recombinant ...
Matexcel, a leading innovator in advanced materials and bioengineering, today announced its diverse portfolio of bio-ink products, empowering researchers across various fields to unlock the potential of 3D bioprinting. This comprehensive range, featuring tailored bio-inks for specific applications, paves the way for revolutionary advancements in regenerative medicine, drug discovery, and beyond. ...
ByMatexcel
Its treatment principle is to transmit ultrasound waves deep into the skin to achieve deeper treatment results. ...
There are also contraindications to fractional laser, severe diabetics, hypertension, pregnancy, breastfeeding and those allergic to light are not allowed to do the treatment. There is a recovery period after treatment, and patients need to pay attention to wound protection and good care. Growth factor drugs can be used to promote ...
For the effect after HIFU treatment, the conditioning of the muscle base before treatment and the repair of the muscle base after treatment are enhanced. The detailed process is: 30-60 days prior to HIFU treatment take Rene One Precision SMAS Multi-stage Dynamic, which effectively replenishes the skin with a large amount of ...
The second asset, now named healiva®002, is an off-the-shelf allogeneic cell therapy that has previously demonstrated clinical efficacy in healing VLUs that are resistant to standard treatments. “We created Healiva® to improve the lives of the millions suffering from chronic wounds by delivering innovative, effective new treatments ...
Applicable people for CO2 fractional laser skin resurfacing treatment The main applicable population of CO2 fractional laser skin resurfacing treatment is all superficial scars and the early stage after wound healing. ...
Cytokine, a subdivision of Creative Proteomics, specializes in providing cytokine research and analytical services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Recently, the product manager of the company is pleased to announce the launch of the growth factors (GF) detection service for further research enhancement. ...
Destiny Pharma is developing the novel formulation of XF-73 Dermal for the prevention of infections associated with open wounds and broken skin including diabetic foot ulcers (DFUs) – up to 25% of US diabetic patients may suffer from DFUs in their lifetime and c. 13% have active ulcers. The XF-73 Dermal product is planned to be a fast, cost-effective dermal ...
She also serves as the co-medical director of the Stanford Advanced Wound Care Center and the program director of the Vascular Surgery Fellowship and Vascular Surgery Residency Programs at the Stanford University School of Medicine. Alucent is currently developing its Natural Vascular Scaffolding (Alucent NVS) Vessel Restoration System with Photoactivated Linking for the ...